MINI FUTURE LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Real-time Borsa Italiana 16:38:44 21/06/2024 BST | ||
| 15.07 EUR | -0.07% |
|
| Current month | +2.86% | ||
| 1 month | -7.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
Latest news about RECORDATI
| Date | Price | Change |
|---|---|---|
| 21/06/24 | 15.07 | -0.07% |
| 20/06/24 | 15.08 | +10.07% |
| 19/06/24 | 13.7 | -4.20% |
| 18/06/24 | 14.3 | +6.72% |
| 17/06/24 | 13.4 | -3.87% |
Real-time Borsa Italiana
Last update June 21, 2024 at 04:38 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | 
BNP Paribas
|
| P1IDV4 | |
| ISIN | NLBNPIT1IDV4 |
| Date issued | 19/10/2022 |
| Strike | 34.36 € |
| Maturity | 18/12/2025 (545 Days) |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.27 € |
|---|---|
| Lowest since issue | 3.22 € |
| Spread | 0.08 € |
| Spread % | 0.54% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.24
EUR
Average target price
52.64
EUR
Spread / Average Target
+6.90%
- Stock Market
- Certificates
- P1IDV4 Certificat
